LMZ(SH:600249) Sou Hu Cai Jing·2025-06-13 23:05Core Viewpoint - The company, Liuzhou Two-Needles Co., Ltd., has faced a decline in profitability and has taken on new short-term loans to benefit from government policies, while also planning to improve its financial performance through innovation and restructuring [1][2]. Company Announcements - The company reported a total cash balance of 1.273 billion yuan at the end of the reporting period, which accounts for 46.78% of total assets, with short-term loans increasing by 55.17% year-on-year to 90 million yuan [1][2]. - The company achieved a net profit of 8.95 million yuan after deducting non-recurring items in 2024, representing a year-on-year decline of 37.13%, with a gross margin of 13.84% for its main business in daily chemical products [1][2]. - The company plans to hold its 2024 annual shareholders' meeting on June 26, 2025, to review six proposals, including the annual report and profit distribution plan [3][5]. Financial Performance - In 2024, the company reported operating revenue of 1.053 billion yuan, a year-on-year increase of 5.82%, and a total profit of 110 million yuan, up 264.59% year-on-year [3][5]. - The total assets of the company amounted to 2.721 billion yuan, with total liabilities of 539 million yuan, resulting in a debt-to-asset ratio of 19.80% [3]. - The company has increased its R&D investment by approximately 10% and has completed several new product development and upgrade projects [3].